« Consultation on the United Kingdom plan for rare diseases: summary of consultation responses | Main | Exploring the early workings of emerging Clinical Commissioning Groups: final report »

16/11/2012

Logo Kings Fund
If you prefer to receive this content via email, you can sign up to our twice-weekly bulletin here: https://www.kingsfund.org.uk/emails